{"paper_id":"d7b0bf22-6f99-45a8-9e5e-96f7494a9872","body_text":"1 \nLongitudinal investigation of spatial memory and retinal 1 \nparameters in a 5xFAD model of Alzheimer’s disease reveals 2 \ndifferences dependent on genotype and sex  3 \n 4 \nGeorg Ladurner,a,b* Conrad W. Merkle,a Lucas May,a Sybren Worm,a Yash Patel,a Maria 5 \nVaraka,a Magdalena Daurer,b Laurenz Jauk,b  Roland Rabl,b Philipp Königshofer,c 6 \nGerhard Garhöfer,d Manuela Prokesch,b Bernhard Baumanna,e 7 \n 8 \naMedical University of Vienna, Center for Medical Physics and Biomedical Engineering, Vienna, Austria 9 \nbScantox Neuro GmbH, Grambach, Austria 10 \ncMedical University of Vienna, Core Facility Laboratory Animal Breeding and Husbandry, Vienna, Austria  11 \ndMedical University of Vienna, Department of Clinical Pharmacology, Vienna, Austria 12 \neMedical University of Innsbruck, Institute of Biomedical Physics, Innsbruck, Austria  13 \n 14 \nAbstract 15 \nSignificance: The retinal phenotype of Alzheimer’s disease (AD) is poorly understood. The connection between 16 \nspatial memory and retinal phenotype is poorly investigated. Additionally, the influence of sex on the disease in mouse 17 \nmodels is not sufficiently clear and requires further investigation.       18 \nAim: To investigate the retina and spatial memory of 5xFAD mouse models  of AD  by measuring retinal and 19 \nbehavioral parameters.  20 \nApproach: A custom-built optical coherence tomography (OCT)  system is used to image the retina of both eyes of 21 \n32 transgenic 5xFAD mice and 32 non -transgenic littermates over the course of 6 months (3 -9 months of age) to 22 \ninvestigate retinal parameters. The Morris Water Maze  (MWM) test was performed to examine correlations between 23 \nthe retinal and spatial memory phenotype of the mouse model.  24 \nResults: Data were acquired in the form of OCT reflectivity images and OCT angiograms as well as video recordings 25 \nof the MWM test. Layer thickness and vascular density w ere calculated from the resulting data. Behavioral data was 26 \nextracted from the videos acquired from the MWM. Total retinal and inner retinal layer thickness increased slightly 27 \nover the measurement period, while outer retinal layer and retinal nerve fiber layer thickness showed no significant 28 \nchange. The correlation  analysis between MWM and layer thickness data revelated a positive correlation between 29 \ninner nuclear layer thickness and MWM test day parameters.     30 \nConclusions: OCT and MWM data revealed sex -based differences in the retinal phenotype of the 5xFAD mouse 31 \nmodel, with changes in retinal thickness in different stages of the study and dissimilar correlations between retinal and 32 \nspatial memory phenotype.  33 \n 34 \nKeywords: Optical Coherence Tomography, Retinal Imaging, Alzheimer’s Disease, 5xFAD Mouse Model, Spatial 35 \nMemory Testing, Morris Water Maze 36 \n 37 \n*Georg Ladurner, E-mail: georg.ladurner@meduniwien.ac.at 38 \n1 Introduction 39 \nAlzheimer’s disease (AD) is the most common form of dementia and represents a huge challenge 40 \nfor modern health care systems in an increasingly aging population. 1 AD-related lesions in the 41 \nbrain include the appearance of amyloid beta plaques, neurofibrillary tangles as well as loss of 42 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n2 \nneurons and synapses on a cellular level. 2 On a behavioral level, clinical signs of AD include 43 \nmemory impairment, irritability, orientational troubles and in later stages also difficulties with 44 \nbasic body functions. 3 Diagnosis of the disease is at this point not fully possible, a definitive 45 \ndiagnosis can only be achieved by postmortem neuropathology.4 Promising diagnostic approaches 46 \ninclude magnetic resonance imaging, positron emission tomography and cerebrospinal fluid 47 \nassays, in all cases in combination with neurological tests. 5 Blood tests have recently emerged as 48 \na new alternative for the detection of AD biomarkers such as phosphorylated tau protein, amyloid 49 \nbeta or neurofilaments , a lthough distinction between AD and non - related dementias  can be 50 \nchallenging due to similar biomarkers. 6 Treatment options for AD are still limited, due to a lack 51 \nof methods to stop or reverse the disease progression. 7 New compounds for AD treatment like 52 \ndonanemab and lecanemab recently received FDA approval, although their efficiency and safety 53 \nhave been disputed.8 The National Institute for Health and Care Excellence  (NICE) even does 54 \nreject the use of donanemab due to significant health risk associated with treatment and high costs.9 55 \nDue to a common embryological origin,  the retina and the brain share similar functionalities as 56 \nwell as disease manifestations.10 For many neurodegenerative diseases, as for example Parkinson’s 57 \ndisease11 or amyotrophic lateral sclerosis (ALS),12 retinal pathologies in parallel to lesions in the 58 \nbrain have been reported. In the case of AD, markers such as inflammation, neurodegeneration as 59 \nwell as amyloid beta deposits and hyperphosphorylated tau aggregates have been reported to 60 \nappear in the retina of patients even at an early stage, 10 although controversial findings have also 61 \nbeen published 13. Whether the appearance of AD makers in the retina can be exploited for 62 \ndiagnostics purposes is still disputed.14 63 \nGiven the difficulty of AD treatment7 and the challenges of diagnosis,5,6 it is crucial to increase 64 \nthe understanding of the retina as a potential diagnosis method of the disease.15 Mouse models are 65 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n3 \na central component of drug testing and the investigation of disease mechanisms16 and are thus an 66 \nimportant subject to increase the understanding of the connection between retinal and cerebral 67 \npathologies of AD. The retinal phenotype of different mouse models of AD has been investigated, 68 \nhowever reporting inconclusive results.17 69 \nOne candidate technology for retinal diagnostics in AD is optical coherence tomography (OCT) . 70 \nOCT is a non-invasive imaging technique often used for in vivo retinal imaging, also in the context 71 \nof neurodegenerative diseases.18 OCT is based on the interference of low-coherent light scattered 72 \nby the sample with a reference beam to reveal information about the sample. OCT can be used to 73 \ngenerate 3D images of tissue, also in real time. 19 Modern OCT technology yields high-resolution 74 \nimages of vasculature20, charts retinal thickness21 and can visualize focal retinal lesions.22 Several 75 \nmouse models of familial AD have been investigated using retinal OCT imaging. In an APP-PS1 76 \nmouse model, retinal thinning was observed in one study,23 whereas no changes could be measured 77 \nby another group. 22 Several studies reported thinning of retinal layers for the 3xTg mouse 78 \nmodels.17 In previous investigation s of the 5xFAD mouse model  of AD thinning of the retinal 79 \nnerve fiber layer (RNFL) and thickening of the inner plexiform layer (IPL) was measured with a 80 \ncommercial OCT device (Leica Envisu R2200) in 6–to 17-month-old mice.24 In a study by Kim et 81 \nal., thinning of the total retina, the inner (IRL) and outer retinal layers (ORL) as well as the RNFL 82 \nwere reported with a spectral domain OCT (SD-OCT) system. Additionally, a decrease in capillary 83 \ndensity was reported for this study with female mice.25 A third study using a commercial SD-OCT 84 \nsystem reported thinning for the RNFL and thickening for the OPL and ONL for male transgenic 85 \n5xFAD mice and C57B L/6J controls at 3 months of age .26 Overall, the retinal phenotype of AD 86 \nmouse models can be considered very controversial and demands careful clarification to enlighten 87 \nthe current landscape of conflicting results.  88 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n4 \nIn addition, the connection of the retinal phenotype with cognitive impairment of the investigated 89 \nmouse models is largely unexplored and leaves room for investigation. Moreover, the potential 90 \ndifferences between female and male mice are often not investigated in the present literature.  Here, 91 \nby using a high-resolution OCT prototype tailored for multi -contrast retinal imaging in mice and 92 \ncombining the data with the assessment of cognitive impairment through behavioral testing , we 93 \naspire to gain new  insights on the development of retinal parameters and unveil potential  94 \nconnections between the appearing phenotypes.   95 \n2 Materials and Methods 96 \n2.1 Animal Model 97 \nThe 5xFAD mouse model (The Jackson Laboratory, strain #008730) is a common transgenic 98 \nmouse model for the investigation of Alzheimer’s disease and has been used in about 10% of 99 \nstudies.27 The mouse line is based on a C57BL/6J background and overexpresses human amyloid 100 \nbeta amyloid precursor protein related to the Swedish (K670N, M671L), Florida (I716V), and 101 \nLondon (V717I) familial Alzheimer's disease (FAD) mutations as well as the human presenilin 1 102 \n(PS1) protein by harboring two FAD mutations, M146L and L286V. 5xFAD mice have been 103 \nreported to present amyloid beta plaque formation in the brain as early as two months of age.27  104 \n2.2 Study Design  105 \n5xFAD mice (32 transgenic, 32 non-transgenic littermates) at 10 weeks (±1 week) of age were 106 \nprovided by Scantox Neuro GmbH. The animals were housed under controlled light conditions 107 \n(12 hours dark, 12 hours light) with food and water ad libitum. Overall health status and weights 108 \nwere monitored every week. Animals were longitudinally investigated over the course of 6 109 \nmonths. OCT scans of animals were taken on five occasions at 12, 20, 24 and 36 weeks of age. 110 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n5 \nSpatial memory was tested at 35 weeks of age using the Morris Water Maze (MWM). The exact 111 \nnumber of animals and the number of transgenic (tg) and non-transgenic (ntg) animals involved 112 \nin each test is listed in Table 1. Note that the animal numbers decrease over the course of the 113 \nstudy because some animals were used for another investigation, which is not part of the research 114 \ndescribed in this work, and thus were extracted from the study at 12 weeks and 24 weeks of age. 115 \nAll experiments were performed in accordance with the ARVO Statement for the Use of 116 \nAnimals in Ophthalmic and Vision Research and Directive 2010/63/EU. All experimental 117 \nprocedures and protocols were approved by the ethics committee of the Medical University of 118 \nVienna and the Austrian Federal Ministry of Education, Science, and Research (GZ 2024-119 \n0.044.300). 120 \nAge [weeks] 12 20 24 35 36 \nNumber of mice examined with OCT  64 48 48 / 27 \nTransgenic  Non-transgenic  32 32 24 24 24 24 / 14 13 \nNumber of mice tested in the MWM / / / 27 / \nTransgenic  Non-transgenic  / / / 14 13  \nTable 1 Number of animals used for each test. 121 \n2.3 OCT System 122 \nThe polarization-sensitive OCT (PS-OCT) system first presented by Fialová et al., was used to 123 \nperform the study.28 The system was based on a super-luminescent diode with a central 124 \nwavelength of 840 nm and a bandwidth of 100 nm, resulting in an axial resolution of ~3.8 µm in 125 \ntissue (n=1.35). The spectrometer line scan cameras acquired the spectral data with 3072 pixels 126 \nfor the co-and cross polarized channels with an A-scan rate of 80 kHz.28 By aligning the mouse 127 \nplaced on a mount providing three axes of translation and two axes of rotation, the imaged field 128 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n6 \nof view was centered at the optic nerve head (ONH) and measured approximately 1mm x 1mm. 129 \nFive repeated B-scans were acquired in 400 positions, resulting in volumes of 2000 B-scans 130 \nconsisting of 512 A-scans. The recorded volumes contained 512x400x3072 spectral voxels.  131 \n2.4 Anesthesia and Imaging  132 \nMice were placed in an anesthesia induction chamber, which was afterwards filled with 4% 133 \nisoflurane (IsoFlo, Zoetis Österreich GmbH) in oxygen for 4 minutes prior to imaging. 134 \nTropicamid drops (0.5%, Agepha Pharma s.r.o.) were applied to dilate the pupils of the animals. 135 \nFor imaging, the mice were transferred to a home-built animal mount and kept under anesthesia 136 \nusing a nose cone applying 2% isoflurane. In some cases, individuals developed resistance to the 137 \nisoflurane during the study, requiring an increased concentration of 2.5% at later imaging 138 \ntimepoints to ensure proper sedation. To prevent hypothermia, the mouse was blanketed with a 139 \nheating pad. Oculotect eye drops (Théa Pharma GmbH) were frequently applied to keep the eyes 140 \nof the animals hydrated during the entire anesthesia sessions. Shortly prior to imaging, excessive 141 \neye drop liquid was carefully removed from the mouse eye using a cotton swab to avoid 142 \nadditional lensing effects. Both eyes were imaged with the ONH in the center of the field of 143 \nview. Several male animals (n(tg) = 3, n(ntg) = 3) deceased during or after anesthesia and could 144 \nnot be investigated for all time points, but no female animals were affected.   145 \n2.5 Image Processing  146 \nImage processing was performed to provide images displaying reflectivity, motion and 147 \npolarization-based contrast, using the pipeline described previously (Augustin et al., 2016). 148 \nRetinal image data were flattened with respect to the retinal pigment epithelium (RPE) detected 149 \nvia its depolarizing properties in the PS-OCT images.29 Data sets that could not be processed in 150 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n7 \nthis first step due to low signal intensity, strong vignetting or acquisition errors, among others, 151 \nwere excluded from the study.  152 \n 153 \n2.5.1 Layer Thickness Analysis 154 \nTo measure retinal layer thickness, the algorithm described by Augustin et al. was used 155 \n(Augustin et al., 2018). The distance between RPE and inner limiting membrane (ILM) was 156 \nconsidered as the total retinal thickness.30 Additionally the thicknesses of the outer retinal layers 157 \n(ORL) and inner retinal layers (IRL) were measured, using the posterior surface of the outer 158 \nplexiform layer as the boundary. The thickness of the retinal nerve fiber layer/ganglion cell layer 159 \ncomplex (RNFL/GCL), the inner (INL), the inner (IPL) and outer plexiform layer (OPL), the 160 \nphotoreceptor complex (PRC) as well as the depolarizing RPE complex were also measured. 161 \nLayer thickness data were stored as 2D en-face maps. To align measurements between all 162 \nanimals, the center of the ONH in each 3D volume was manually annotated and the central circle 163 \nwith 200 µm in diameter was removed from further analysis. The rest of the volume was divided 164 \ninto four sectors (superior, nasal and inferior, temporal), using the diagonals of the 1x1 mm² 165 \nsquare as borders and into radial zones equidistant from the center. Then a zone with an inner 166 \nradius of 200 µm and an outer radius of 600 µm distance from the ONH is selected. The average 167 \nthickness of the total retinal thickness and the thickness of the sublayers was calculated in this 168 \nannular zone. Thickness maps were manually screened during post processing and volumes with 169 \ninsufficient quality to produce a reliable segmentation of the retinal layers were excluded from 170 \nthe study. When two or more acquisitions of the same eye and timepoint were available, the scan 171 \nwith best signal quality or most centered ONH was used. When neither of the scans was 172 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n8 \nsignificantly better than their counterparts, the resulting thickness measurements were averaged 173 \nbetween both scans. This resulted in the number of thickness maps listed in Table 2.  174 \nAge [weeks] 12 20 24 36 \nNumber of analyzed volume scans 125 87 86 50 \nTransgenic  Non-transgenic  61 64 41 46 44 42 25 25 \nTable 2 Number of individual volumetric OCT scans used for retinal layer thickness analysis. 175 \n2.5.2 Angiography 176 \nOCT angiography (OCTA) data were computed as described in reference 22. Volumetric OCTA 177 \ndata were divided into three slabs using the layer segmentation described in section 2.5.1: the 178 \nsuperior vascular plexus (SVP) in the RNFL/GCL complex, the intermediate capillary plexus 179 \n(ICP) between the RNFL and the INL, and the deep capillary plexus (DCP) between the INL and 180 \nthe ONL. Using thresholding at 10 dB above the noise floor and a Frangi filter, binarized en-face 181 \nimages of the vascular plexuses were created, and a margin measuring 10 pixels at the border 182 \nwas set to zero to avoid border artifacts. Using the manually selected ONH position previously 183 \nused for the quantification of retinal layer thickness, a circle around the ONH was cut out from 184 \nthe binarized images. The signal-to-noise ratio (SNR) was calculated for the regions visible in 185 \nFigure 1(D), and the image was divided into four regions along the diagonals and then again into 186 \nrings with 100 µm thickness, each of the zones has an individual SNR value. The binarized 187 \nimages were multiplied with the SNR map of the scan shown in Figure 1(D), thus assigning the 188 \nvalues to the binarized image as exemplified in Figure 1(E). The regions whose SNR was below 189 \na predefined threshold were not used for further evaluation and were thus set to zero (see Figure 190 \n1(F)). For SVP and ICP, the threshold was set to 20 dB, while for the DCP, the threshold was set 191 \nto 15 dB since the signal in this region was generally lower. In the case displayed in Figure 1, the 192 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n9 \nregions in the corners and around the ONH did not display above threshold SNR and were 193 \nremoved. By inverting only the pixels in the regions with above-threshold SNR, a negative 194 \nimage was created. By counting the positive pixels in the regions with above-threshold SNR 195 \n(Figure 1(G)) and the negative pixels in the same regions (Figure 1(F)), the area vessel density 196 \nwas calculated for each vascular plexus. 197 \n 198 \nFig 1: Example for the calculation of vessel density in the DCP. (A) Raw OCTA data after layer segmentation of the 199 \n3D stack, (B) binarized image with borders set to zero (C) removal of the circular region centered at the ONH from 200 \nthe binarized image, (D) SNR sector map, rings have a thickness of 100 µm (E) application of the SNR on the 201 \nbinarized image, (F) removal of the regions with SNR below threshold and creation of the negative for counting 202 \npixels. 203 \nThe OCTA data was sorted similar to the retinal layer analysis. Additionally the data was 204 \nscreened manually, to only include the best available datasets. Table 3 presents the number of 205 \ndatasets that yielded at least one measurement for the 3 different vascular regions and thus were 206 \nused for the longitudinal OCTA analysis.  207 \nTimepoint [weeks] 12 20 24 36 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n10 \nNumber of analyzed volume scans 119 84 85 50 \nTransgenic  Non-transgenic  64 55 41 43 43 42 25 25 \nTable 3 Number of individual volumetric OCTA datasets used for angiography. 208 \n2.6 Morris Water Maze 209 \nSpatial memory capabilities of the animals were tested in a custom-built Morris Water Maze 210 \n(MWM) setup.31 The maze consisted of a water filled pool, one meter in diameter and 211 \nsurrounded by opaque curtains, a translucent platform (8 cm diameter) and four distinct 212 \nlandmarks as illustrated in Figure 2(A). A monochrome camera with 5 megapixels resolution and 213 \n14 fps (Basler Ace Classic, acA2500-14uc) was mounted 1.5 m above the pool and the 214 \nlandmarks placed in the middle of each of the four sides surrounding the pool, to avoid any 215 \nadditional orientation points for the mice. Movie data were acquired by using the Basler Video 216 \nRecording software (version 1.3). The northeastern quadrant contained a translucent platform 217 \n(target zone) about 1 cm below water level, such that it was invisible for the mice. The pool 218 \ntemperature was kept between 21-22°C, and the light intensity at the water surface level was 219 \ncontrolled to be around 50 lux. The pool was divided into four quadrants to randomize the 220 \nstarting position (see Figure 2(B)). The starting positions were defined as per Table 4 and were 221 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n11 \napplied to every mouse to assure an equal distribution of starting positions. 222 \n 223 \nFig. 2: Schematic of the Morris Water Maze set-up. (A) Division of the pool into quadrants for the randomization of 224 \nstarting positions. (B) Schematic of the pool set up with landmarks and camera placement.  225 \n 226 \nTrial 1 2 3 4 5  \nTask \n \n Training   Training   Training   Training  Test day Platform \nposition \n(for all \ntrials) \nDay 1 NE SE SW SE / NW \nDay 2 SW NE SE SW / NW \nDay 3 SE SW NE SW / NW \nDay 4 NE SE SW NE / NW \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n12 \nDay 5 / / / / SE / \nTable 4 Starting positions for each training and the test day. Quadrants: NE = northeast, SE = southeast, SW = 227 \nsouthwest, NW = northwest. 228 \n 229 \nThe testing protocol included four consecutive training sessions and one test day. A training day 230 \nconsisted of four trials, where each mouse was placed in the pool (in varying quadrants as 231 \noutlined in Table 4) for a maximum of 60 seconds and had to find the hidden platform. When a 232 \nmouse was not able to find the platform within this time, it was placed on the platform and left 233 \nthere for ten seconds to memorize the position. In case the mouse managed to find the platform, 234 \nthe recording was stopped, and the mouse was removed from the pool. The time between daily 235 \ntrials was 10 minutes. On the test day, the hidden platform was removed, and the mice were 236 \nplaced in the pool once for one minute. Each trial was recorded using the top-down mounted 237 \ncamera.  238 \nFor data evaluation an automatic tracking system, namely Noldus EthoVision XT 14, was used. 239 \nFor the training days, latency to find the platform [s], distance traversed [m], as well as the 240 \npercentage of time spent floating and thigmotaxis (time spent close to the pool walls) was 241 \nmeasured. 32 For the test day, the abidance in each of the of the quadrants and the number of 242 \ncrossings of the target zone were evaluated. The resulting data were analysed in GraphPad 243 \nPrismTM 10.  244 \n2.7  Statistical Analysis 245 \nFor the longitudinal analysis of the retinal parameters, a mixed intercepts model was applied to 246 \ninvestigate age dependent effects and account for multiple measurements per mouse. For 247 \ncomparison between groups at each timepoint, a t-test was applied. P-values smaller than 0.05 248 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n13 \nwere considered significant.  249 \nTo assess whether retinal layer thickness and vessel density data were correlated with spatial 250 \nmemory impairment, the OCT and MWM parameters were analyzed using linear regression. If 251 \ndata for both eyes of a mouse was available, the average of the two values was used as one single 252 \ndatapoint for the analysis. Additionally, the weight of the animals was also included in the 253 \nanalysis. Linear correlation coefficients, R-squared, mean squared error (MSE) intercept and the 254 \nlinear regression coefficient were calculated using a custom Python script. Pearsons’s correlation 255 \nanalysis was used to calculate the correlation coefficients and the corresponding p-values.  256 \n3 Results  257 \n3.1  Longitudinal Development of Retinal Layer Thickness  258 \nThe longitudinal analysis of the total retinal thickness reveals an overall thickening of the retina 259 \nfor male animals by 5.7 µm (p=0.0029) from the beginning to the end of the study. Overall 260 \nretinal thickness increases significantly by 5.8 µm (p=0.0051) for all animals in the study 261 \nduration. Significant differences between groups were observed between tg male and female 262 \nanimals, as well as for ntg male and female animals at 3 months of age. Tg male animals 263 \n(225.4±7.1µm) had significantly thicker retinas than tg female animals (221.1±7.8µm) 264 \n(p=0.014), also for ntg animals, male mice (224.4±7.3µm) displayed a higher total retinal 265 \nthickness than female animals (218.5±10.7µm) (p=0.0298). Other significant differences were 266 \nfound between male and female ntg animals at 6 months of age, where male animals 267 \n(223.6±3.6µm) showed significantly higher total retinal thickness than females (220.5±4.5µm) 268 \n(p=0.0236), and between male and female tg mice at 9 months of age: Male tg mice had 269 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n14 \nsignificantly thicker retinas (228.0±6.4µm) than female tg mice (220.0±6.5µm) (p=0.0386) for 270 \nthe latest measurement point.  271 \n 272 \nFig. 3: Longitudinal measurement of the total retinal thickness for all mice divided by genotype and sex. Individual 273 \npoints represent singular measurements for one mouse eye. Significant differences between groups are marked with 274 \nbrackets above the boxes and annotated with the corresponding p-values.    275 \nFollowing the analysis of total retinal thickness, the retinas were segmented into IRL (RNFL, 276 \nIPL, INL) and ORL (PRC, RPE and OPL) to evaluate the thickness of these retinal sublayers. 277 \nFigure 4 shows the time development of the IRL (A) and the ORL (B). The mixed effects model 278 \nyielded a significant thickness increase of the ORL of 3.8 µm (p=0.0048) for all mice over the 279 \ncourse of the investigation. Significant thickening of the IRL in comparison to the measurements 280 \nat 3 months of age could not be detected (p=0.0503). Significant group differences for the IRL 281 \nmeasurements were observed at 3, 5 and 9 months of age. At 3 months of age male, tg mice 282 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n15 \n(97.3±3.7µm) showed a significantly higher IRL thickness than female tg mice (94.7±5.0µm) 283 \n(p=0.0215). This was also observed for ntg mice, where male mice (96.7±4.1µm) had thicker 284 \nIRL than female ntg mice (94.4±3.9µm) (p=0.0228). For 9 months old mouse models, the IRL 285 \nthickness of tg male mice (98.16±3.19µm) was significantly larger than for ntg male mice 286 \n(95.4±2.1µm) (p=0.0363), and also in comparison with female tg mice (94.7±4.0µm), male tg 287 \nmice had significantly (p=0.0331) thicker IRL. For the measurements of the ORL, no significant 288 \nchanges were observed for the last measurement at 9 months of age. 289 \n 290 \nFig. 4: Longitudinal measurement of the IRL (A) and ORL (B) for all mice divided by genotype and sex. Individual 291 \npoints represent singular measurements for one mouse eye. Significant differences between groups are marked with 292 \nbrackets above the boxes and annotated with the corresponding p-values.    293 \nAs a next step, the sublayers of the IRL (INL, RNFL and IPL) were individually investigated to 294 \nassess potential changes over time and between groups. Neither of these retinal sublayers showed 295 \nsignificant changes in thickness over the study time of 6 months. For the INL measurements, the 296 \nanalysis yielded significantly different thicknesses for male and female tg animals, where male tg 297 \nanimals displayed a thickness of 26.8 ±1.3µm, significantly thicker than female tg animals with 298 \n27.2 ±1.4µm (p=0.0109). Significant thickness differences also appeared between ntg male and 299 \nfemale, as well as between tg male and female mice at 5 months of age. The investigation of 300 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n16 \nRNFL thickness showed significantly higher values for male tg animals (33.9±6.2µm) than for 301 \nfemale tg mice (29.4±5.6µm) (p=0.0041). For 5 months of age, a thicker RNFL for ntg male 302 \nanimals than for tg male animals was observed as well. For the final measurement with 9-month-303 \nold animals, no significant differences were observed for the three inner retinal layers.  304 \n 305 \nFig. 5: Longitudinal measurement of the INL (A), RNFL (B) and IPL (C) for all mice divided by genotype and sex. 306 \nIndividual points represent singular measurements for each one mouse eye. Significant differences between groups 307 \nare marked with brackets above the boxes and annotated with the corresponding p -values.   308 \nThe ORL consists of the PRC, the OPL and the RPE. Figure 6 shows the development of 309 \nthickness over time for these layers.  An overall thickening of the PRC for all animals by 310 \n2.6±1.3µm (p=0.0350) over the study duration was observed for. Significant differences between 311 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n17 \ngroups were found for ntg male and female animals for 3 and 6 months of age. However, similar 312 \nchanges in layer thickness were not observed for the measurements at 5 and 9 months of age. For 313 \nthe OPL, an overall thickening of the layer was measured (1.1±0.3µm) (p=0.0003) for all 314 \nanimals. At the last measured timepoint, female ntg animals showed a significantly thicker OPL 315 \n(12.7±1.2µm) compared to female tg animals (11.7±0.6µm) (p=0.0128).  316 \nFor the RPE data, the mixed effects models showed an overall lower RPE thickness for tg 317 \nanimals of about 0.5±0.24µm (p=0.036). Changes over time for the RPE were not identified. 318 \nSimilar to the OPL, female ntg animals had a different RPE thickness than tg female animals at 9 319 \nmonths of age. With 11.6±1.1µm, the female ntg animals display a significantly thicker RPE 320 \nthan the tg animals with 10.6 ±0.4µm (p=0.0058). Note that the RPE thickness measurements 321 \nprovided here reflect the segmented thickness of the depolarizing layer.28 Further significant 322 \nchanges were measured for PRC thickness between male (115.7±3.5µm) and female 323 \n(112.5±7.8µm) ntg animals at 3 months of age (p=0.0394), between tg (11.0±0.7µm) and ntg 324 \n(11.7±1.3µm) male animals at 5 months of age for OPL (p=0.0423) and for tg (10.3±0.6µm) and 325 \nntg (11.1±1.0µm) male animals at 5 months of age for the RPE thickness (p=0.0036).  326 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n18 \n 327 \nFig. 6: Longitudinal measurement of the PRC (A), OPL (B) and RPE (C) for all mice divided by genotype and sex. 328 \nIndividual points represent singular measurements for one mouse eye. Significant differences between groups are 329 \nmarked with brackets above the boxes and annotated with the corresponding p -values.    330 \n 331 \n3.2  Angiography   332 \nSignificant differences were observed between male ntg and tg mice at 9 months of age for the 333 \nSVP and ICP measurements. The SVP density for ntg male mice (19.8±1.6%) was significantly 334 \nlower (p=0.0063) than for male tg mice (22.1±1.5%). The mixed intercepts model revealed a 335 \nsignificant (p=0.025) density decrease of about 2% for male mice over the course of the study 336 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n19 \nfrom 3 months until 9 months of age. Significant differences were also observed between ntg 337 \nmale and ntg female mice with lower values for ntg male mice (p=0.0047) at 9 months of age 338 \nand for female ntg and female tg mice at 5 months of age (p=0.0365, see Figure 7(A)). Male ntg 339 \nmice also experienced an ICP density decrease over the course of the longitudinal investigation. 340 \nThe mixed effects model yielded a significant decrease of 3.6% in density for all male mice 341 \n(p=0.039) and 5.4% for male ntg mice (p=0.025) from the baseline measurement to the endpoint. 342 \nSignificant differences between ntg male and tg male mice can be observed at 9 months of age. 343 \nWith 6.8±1.4%, ntg male mice showed significantly lower density than tg male mice with 344 \n9.9±2.5% (p=0.0023). Male ntg mice also had significantly lower densities than female ntg mice 345 \n(p=0.0292). Ntg male mice also showed significantly lower ICP density than female ntg mice at 346 \n5 months of age (p=0.0207, see Figure 7(B)). In contrast to these findings in the SVP and ICP, 347 \nno significant changes over time or between individual groups were observed for the 348 \nmeasurement of the DCP density (Figure 7(C)). 349 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n20 \n 350 \nFig. 7: Longitudinal measurements for vascular density in percentage of area (A) SVP density, (B) ICP density, (C) 351 \nDCP density. Significant differences between groups are marked with brackets above the boxes and annotated with 352 \nthe corresponding p-values.    353 \n 354 \n3.3  Spatial Memory Testing  355 \n3.3.1 MWM at 35 weeks of age  356 \nAll remaining animals (n=27) were retested in the same MWM set-up at the age of 35 weeks. As 357 \nshown in Figure 8, no significant differences between the tg and ntg animals can be observed for 358 \nthe experiment. For female animals, significant differences were observed for the latency to find 359 \nthe platform on the fourth training day (Figure 9 (A)). For the other parameters, no changes can 360 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n21 \nbe observed. 361 \n 362 \nFig. 8: MWM results for animals at 35 weeks of age. (A) Latency to find the target platform, (B) distance traversed, 363 \n(C) floating behavior, and (D) thigmotaxis over the four training days. (E) Abidance in target quadrant and (F) 364 \nnumber of target zone crossings on the test day. Whiskers indicate ± the standard deviation (SD). 365 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n22 \n 366 \nFig. 9: MWM results for female animals at 35 weeks of age. (A) Latency to find the target platform, (B) distance 367 \ntraversed, (C) floating behavior, and (D) thigmotaxis over the four training days. (E) Abidance in target quadrant 368 \nand (F) number of target zone crossings on the test day. Whiskers indicate ± the standard deviation (SD). 369 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n23 \n 370 \nFig. 10: MWM results for male animals at 35 weeks of age. (A) Latency to find the target platform, (B) distance 371 \ntraversed, (C) floating behavior, and (D) thigmotaxis over the four training days. (E) Abidance in target quadrant 372 \nand (F) number of target zone crossings on the test day. Whiskers indicate ± the standard deviation (SD). 373 \nMale animals displayed no significant differences in the comparison with ntg  animals in the 374 \nMWM test.  375 \n3.4  Correlation between retinal parameters and spatial memory   376 \nThe correlation analysis between retinal parameters and values obtained from the spatial memory 377 \ntesting revealed a significant association between the INL thickness and the MWM parameters of 378 \nthe test day (day 5) for female transgenic mice. The number of target zone crossings (Figure 11 379 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n24 \n(D-F)) as well as the percentage of time spent in the target sector (Figure 12 (D-F)) correlated 380 \nstrongly with the thickness of the INL (0.87, 0.86), the IRL (0.77, 0.74) and the total retina (0.76, 381 \n0.69). Pearson’s correlation coefficient was the highest for the INL with 0.87 (p=0.0054) for the 382 \nnumber of target zone crossings and 0.86 (p=0.0060) for the time spent in the target sector. 383 \nThese correlations were only observed for female transgenic mice. For male transgenic mice, no 384 \ncorrelation between layer thickness measurements and MWM parameters was observed for the 385 \ntest day. Combining the two groups and looking at the correlation for all transgenic animals 386 \nrevealed a statistically significant correlation between the two investigated MWM parameters 387 \nand the IRL (0.54) and INL (0.62), respectively, as shown in Figures 11 (B, C) and 12 (B, C).  388 \n 389 \nFig. 11: Correlation and linear regression between total retinal (left), IRL (middle) and INL thickness (right) with 390 \nnumber of target zone crossings for all transgenic mice (A-C), female transgenic mice (D-F) and male transgenic 391 \nmice (G-I). The respective Pearson correlation coefficient (Corr) and p-value as well as R2 and mean squared error 392 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n25 \n(MSE) resulting from the linear regression are indicated below each graph. For each plot, the colored line represents 393 \nthe linear regression. 394 \n 395 \nFig. 12: Correlation and linear regression between total retinal (left), IRL (middle) and INL thickness (right) with % 396 \nof time spent in the target sector for all transgenic mice (A-C), female transgenic mice (D-F) and male transgenic 397 \nmice (G-I). Below each graph, the respective Pearson correlation coefficient and p-value as well as R2 and MSE for 398 \nthe linear regression are indicated. The colored line represents the respective linear regression. 399 \nAdditionally, the ICP density correlated with thigmotactic behavior for female transgenic mice 400 \n(Corr=0.76, p=0.047) and the PRC thickness correlated negatively with floating behavior (Corr= 401 \n-0.82, p=0.0126). For male transgenic animals , no correlations between MWM and retinal 402 \nparameters were found. Furthermore, the weight of the male transgenic animals strongly correlated 403 \nwith the SVP density (Corr=0.96, p=0.008). Tables with all compared parameters  for all animal 404 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n26 \ngroups (tg, tg females, tg males, ntg, ntg females and ntg males) including correlation coefficients, 405 \np-values, R2 and MSE are provided in the supplementary information (Table 1-12).  406 \n4 Discussion  407 \nIn this investigation, longitudinal OCT imaging of a 5xFAD mouse model was performed in 408 \nparallel to spatial memory testing and uncovered pronounced differences in retinal parameters 409 \ndependent on both genotype and sex . Our analysis of retinal layer thickness revealed subtle but 410 \nsignificant thickening of the total retina over the course of the study. Thickening was also observed 411 \nfor the ORL, where in particular  the PRC and the OPL thickness increased over time. In the 412 \nlongitudinal investigation, c onsistent thinning was not detectable for any retinal layers from 3 413 \nmonths to 9 months of age. However, thickness differences were observed for group comparison 414 \nat individual measurement timepoints. Our comparison between the groups at the last measurement 415 \npoint at 9 months of age resulted in the detection of several parameters with statistically significant 416 \ndifferences. Here the total retina and the IRL of tg male mice was significantly thicker than for tg 417 \nfemale mice. The IRL layers for tg male mice were also significantly thicker than for the ntg male 418 \nmice indicating a swelling of the IRL for male mice. For female mice , OPL and RPE thickness 419 \nsignificantly thin in comparison to ntg female mice at 9 months of age. The longitudinal analysis 420 \nof OCT angiography data did not show changes for neither ntg nor tg female mice. However, for 421 \nmale ntg mice, a significant density loss in the SVP and ICP was observed over time, leading to 422 \nsignificant differences when comparing the group to tg male mice. The observed changes in retinal 423 \nlayer thickness and vascular density differed strongly between male and female mice indicating a 424 \ndependence of the phenotype on sex. Changes in angiographic parameter s depended more on the 425 \nsex of animals than on their genotype. The differences in retinal layer thickness also appeared very 426 \ndifferently dependent on the sex of animals. 427 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n27 \nThe correlation analysis of the MWM data and the retinal parameters revealed an association 428 \nbetween the thickness of the total retina, the IRL and the INL with the number of target zone 429 \ncrossings (NTZC) and the time spent in the target sector (TSTS) on the test day. Both parameters 430 \nfor the MWM – although not completely independent of each other – are measures of spatial 431 \nmemory capabilities. The strongest correlation was observed between these parameters and the 432 \nINL thickness of female tg mice. The correlation between the NTZC and TSTS with the IRL as 433 \nwell as the total retinal thickness for female mice is likely due to their strong correlation with the 434 \nINL. For male tg mice, no significant positive correlation between total retina, IRL and INL layer 435 \nthickness was measured. With a correlation coefficient of 0.65 for INL and TSTS, correlation 436 \nbetween the two parameters can still be observed . Combining this information with the sex 437 \ndifferences in layer thickness, we conclude a strong sex influence on the retinal phenotype of the 438 \n5xFAD mouse model and its connection to spatial memory. 439 \nOur results partly differ from data reported in other studies on 5xFAD mice . Lim and coworkers 440 \nobserved RNFL thinning and OPL thickening in the investigation of 32 tg and 38 ntg mice with 441 \nunspecified sex.24 In contrast, we did not observe RNFL thinning, although our investigation did 442 \nindicate (non-significant) thickening of the OPL.  Given that the sex specifications were missing 443 \nin that publication, it was not possible to perform a clear comparison of our data with this previous 444 \nmeasurement. We do want to stress  that the gender composition of the investigated animals is  445 \nespecially relevant given the strong impact of sex on the results measured in this study and in AD 446 \nmouse models in general.33 The inclusion of more female or male tg or ntg control animals could 447 \nshift the outcome of the measured results  considerably.  448 \nIn another study, Matei et al. performed OCT on 16 male tg 5xFAD mice in comparison with 10 449 \nC57BL/6J and 6 C57BL/6 mice. In 3-months-old tg mice, the authors do not report changes in the 450 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n28 \ntotal retinal thickness measured with OCT .26 Our investigation confirms these findings  for male 451 \nanimals. Of note, this study did not use littermates, but C57BL/6J and C57BL/6 as controls, using 452 \ntwo different control strains may bias the results.26  453 \nIn their 2021 study, Kim et al. performed an OCT investigation in a female-only cohort of 5 tg and 454 \n6 ntg animals at 6 months of age.25 The chosen control animals were of the associated background 455 \nstrain (B6SJLF1/J), hence a comparison with our data on female 5xFAD mice should be straight-456 \nforward. Still, we cannot confirm their findings of retinal thinning in the total retina, the RNFL, 457 \nthe IRL and ORL at 6 months of age.  On the other hand, our measurements confirm the absence 458 \nof changes in vascular density for SVP, ICP and DCP. 25  459 \nGiven that we investigated 44 tg (22 female, n=12) and 42 ntg (19 female, n=12) volume scans for 460 \nmice at 6 months of age, the lack of overlap with the previously reported results is surprising and 461 \ncan probably be attributed to a number of differences in the study protocols. One potential reason 462 \nfor this is the use of differing anaesthesia agents in the mentioned studies, as ketamine/xylazine 463 \nwas used by Kim et al.,  Lim et at., and Matei et al.,  whereas our study used isoflurane. 24,25,26 464 \nAdditionally, genetic drift,  breeding, body temperature of animals, anaesthesia time, blood 465 \npressure, time of imaging, eye drops as well as diet and housing conditions (e.g., single vs. group 466 \nhousing) could potentially – and in some cases do – differ between the studies and can influence 467 \nthe outcome of experiments. For this reason, we want to stress that there is a lack of standardization 468 \nin the research field that makes the replication and confirmation of results extremely difficult. 469 \nWithout a description of every detail in the study protocol , results might considerably differ 470 \nbetween research groups.  This also applie s to the comparison between mouse models. Retinal 471 \nchanges were reported for several other mouse models, some with partially overlapping knock -in 472 \ngenes (3xTg) or modelling similar disease aspects (APP/PS1 mouse for amyloid pathology) as the 473 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n29 \n5xFAD mouse model. 17 Another factor that should be considered is the regional dependency of 474 \nretinal thinning, as for example measured in 3xTg mice, w here the longitudinal development of 475 \nsub-layer thickness differs depending on the distance to the ONH. 34 Given the variety in imaging 476 \nprotocols and aforementioned factors,  as well as varying data analysis approaches,  a reliable 477 \ncomparison of OCT findings of retinal pathologies in mouse models seems currently only possible 478 \nif done in the same research group, leaving a significant knowledge gap in the investigation of the 479 \nretinal phenotype of the AD disease. Since most AD mouse models only model one or few aspects 480 \nof the disease pattern, comparability between studies and thus models is critical for the research of 481 \nthe retinal pathology of AD and the translatability of the results to human AD diagnostics. 482 \nGender-specific medicine is crucial for drug development, diagnostics and treatment. It is therefore 483 \nalso increasingly important to discover sex-based differences in mouse models of disease and take 484 \nthese into account for preclinical studies. The study presented in this work represents not only the 485 \nmost extensive longitudinal OCT investigation of the 5xFAD mouse model to date, but also reveals 486 \nsex-based differences in comparisons of retinal parameters with the spatial memory phenotype of 487 \nthe mouse models, thus adding more knowledge to further improve targeted research in the field 488 \nof AD. 489 \n5 Conclusion 490 \nThe presented study investigated retinal parameters in the 5xFAD mouse model of AD over the 491 \ncourse of 6 months providing insights into the progression of retinal pathologies, especially the 492 \nrespective retinal thickness changes for male and female mice, as well as the decay in vascular 493 \ndensity for ntg male mice. By correlating retinal parameters with the spatial memory phenotype 494 \nof the investigated animals, a connection between INL thickness and MWM performance was 495 \nobserved for female tg animals, expanding the knowledge on the interaction between phenotypes 496 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n30 \nfor this particular model of AD. Our investigation proves that a multidisciplinary approach, with 497 \nretinal imaging and behavior analysis, can provide more comprehensive and complementary 498 \ninformation, which may help understanding the concurrent development of different aspects of 499 \nAD. Additionally, this study shows that a separate analysis of female and male mice, as well as 500 \nthe minute control of experimental conditions are crucial for the generation of unbiased results in 501 \nthe investigation of the retinal phenotype in mouse models of AD.  502 \n 503 \nDisclosure 504 \nMagdalena Daurer, Laurenz Jauk, Roland Rabl and Manuela Prokesch are employees of Scantox 505 \nNeuro GmbH. All other authors declare that there are no financial interests, commercial 506 \naffiliations, or other potential conflicts of interest that could have influenced the objectivity of this 507 \nresearch or the writing of this paper. 508 \n 509 \nAcknowledgments 510 \nThe authors want to thank And reas Hodul for his help in constructing the MWM set -up and the 511 \nmouse imaging stage . We are grateful to  Sonja Reynoso-De-Leon, Christian Schönauer , Jasmin 512 \nRezek and the te am in the animal facility for their irreplaceable assistance with the mice. 513 \nAdditionally, we want to thank Patrick Bilic  and Eva Fuchs for their support and guidance on 514 \nanimal welfare related issues , and  Robin Ristl (Center for Medical Data Science, Medical 515 \nUniversity of Vienn a) for assistance with the statistical analysis. Funding for this project was 516 \nprovided by Scantox Neuro GmbH, the FFG grant 900435, the ERC Proof of Concept grant 517 \n101069344 OPTIMEYEZ and the Austrian Science Fund grant I6092-B.  518 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n31 \nCode, Data, and Materials Availability 519 \nAll data in support of the findings of this paper are available within the article  and as 520 \nsupplementary material.  Raw data can be requested from the author at 521 \ngeorg.ladurner@meduniwien.ac.at. . 522 \nReferences 523 \n1. Health Organization, W. Global Status Report on the Public Health Response to 524 \nDementia. (2021). 525 \n2. Serrano-Pozo, A., Frosch, M. P., Masliah, E. & Hyman, B. T. Neuropathological 526 \nalterations in Alzheimer disease. Cold Spring Harb Perspect Med 1, (2011). 527 \n3. Chatterjee, S. & Mudher, A. Alzheimer’s disease and type 2 diabetes: A critical 528 \nassessment of the shared pathological traits. Frontiers in Neuroscience vol. 12 Preprint at 529 \nhttps://doi.org/10.3389/fnins.2018.00383 (2018). 530 \n4. King, A., Bodi, I. & Troakes, C. The neuropathological diagnosis of alzheimer’s 531 \ndisease—the challenges of pathological mimics and concomitant pathology. Brain Sci 10, 532 \n1–23 (2020). 533 \n5. Leuzy, A., Heurling, K., Ashton, N. J., Schöll, M. & Zimmer, E. R. In Vivo Detection of 534 \nAlzheimer’s Disease. YALE JOURNAL OF BIOLOGY AND MEDICINE vol. 91 (2018). 535 \n6. Alawode, D. O. T. et al. Transitioning from cerebrospinal fluid to blood tests to facilitate 536 \ndiagnosis and disease monitoring in Alzheimer’s disease. Journal of Internal Medicine 537 \nvol. 290 583–601 Preprint at https://doi.org/10.1111/joim.13332 (2021). 538 \n7. Thangwaritorn, S. et al. A Review of Recent Advances in the Management of Alzheimer’s 539 \nDisease. Cureus 16, e58416 (2024). 540 \n8. Espay, A. J., Kepp, K. P. & Herrup, K. Lecanemab and Donanemab as Therapies for 541 \nAlzheimer’s Disease: An Illustrated Perspective on the Data. eNeuro vol. 11 Preprint at 542 \nhttps://doi.org/10.1523/ENEURO.0319-23.2024 (2024). 543 \n9. Mahase, E. Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-544 \nALZ 2 Randomized Clinical Trial. JAMA 330, 512–527 (2024). 545 \n10. Mirzaei, N. et al. Alzheimer’s Retinopathy: Seeing Disease in the Eyes. Frontiers in 546 \nNeuroscience vol. 14 Preprint at https://doi.org/10.3389/fnins.2020.00921 (2020). 547 \n11. Zhang, Y., Zhang, X., Yue, Y. & Tian, T. Retinal Degeneration: A Window to Understand 548 \nthe Origin and Progression of Parkinson’s Disease? Frontiers in Neuroscience vol. 15 549 \nPreprint at https://doi.org/10.3389/fnins.2021.799526 (2022). 550 \n12. Soldatov, V. O., Kukharsky, M. S., Belykh, A. E., Sobolev, A. M. & Deykin, A. V. 551 \nRetinal damage in amyotrophic lateral sclerosis: Underlying mechanisms. Eye and Brain 552 \nvol. 13 131–146 Preprint at https://doi.org/10.2147/EB.S299423 (2021). 553 \n13. den Haan, J. et al. Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s 554 \ndisease retinas. Acta Neuropathol Commun 6, 147 (2018). 555 \n14. Ashraf, G. et al. Retinal imaging biomarkers of Alzheimer’s disease: A systematic review 556 \nand meta-analysis of studies using brain amyloid beta status for case definition. 557 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n32 \nAlzheimer’s and Dementia: Diagnosis, Assessment and Disease Monitoring vol. 15 558 \nPreprint at https://doi.org/10.1002/dad2.12421 (2023). 559 \n15. Chiquita, S. et al. The Retina as a Window or Mirror of the Brain Changes Detected in 560 \nAlzheimer’s Disease: Critical Aspects to Unravel. Molecular Neurobiology vol. 56 5416–561 \n5435 Preprint at https://doi.org/10.1007/s12035-018-1461-6 (2019). 562 \n16. Zhong, M. Z., Peng, T., Duarte, M. L., Wang, M. & Cai, D. Updates on mouse models of 563 \nAlzheimer’s disease. Molecular Neurodegeneration vol. 19 Preprint at 564 \nhttps://doi.org/10.1186/s13024-024-00712-0 (2024). 565 \n17. Sánchez-Puebla, L. et al. OCT Imaging in Murine Models of Alzheimer’s Disease in a 566 \nSystematic Review: Findings, Methodology and Future Perspectives. Biomedicines vol. 12 567 \nPreprint at https://doi.org/10.3390/biomedicines12030528 (2024). 568 \n18. Minakaran, N., de Carvalho, E. R., Petzold, A. & Wong, S. H. Optical coherence 569 \ntomography (OCT) in neuro-ophthalmology. Eye (Basingstoke) vol. 35 17–32 Preprint at 570 \nhttps://doi.org/10.1038/s41433-020-01288-x (2021). 571 \n19. Aumann Silke, Fischer Jörg, Müller Frank & Donner Sabine. High Resolution Imaging in 572 \nMicroscopy and Ophthalmology New Frontiers in Biomedical Optics Forewords By. 573 \n(2019). 574 \n20. de Carlo, T. E., Romano, A., Waheed, N. K. & Duker, J. S. A review of optical coherence 575 \ntomography angiography (OCTA). International Journal of Retina and Vitreous vol. 1 576 \nPreprint at https://doi.org/10.1186/s40942-015-0005-8 (2015). 577 \n21. den Haan, J., Verbraak, F. D., Visser, P. J. & Bouwman, F. H. Retinal thickness in 578 \nAlzheimer’s disease: A systematic review and meta-analysis. Alzheimer’s and Dementia: 579 \nDiagnosis, Assessment and Disease Monitoring 6, 162–170 (2017). 580 \n22. Harper, D. J. et al. Retinal analysis of a mouse model of Alzheimer’s disease with 581 \nmulticontrast optical coherence tomography. Neurophotonics 7, 1 (2020). 582 \n23. Georgevsky, D., Retsas, S., Raoufi, N., Shimoni, O. & Golzan, S. M. A longitudinal 583 \nassessment of retinal function and structure in the APP/PS1 transgenic mouse model of 584 \nAlzheimer’s disease. Transl Neurodegener 8, (2019). 585 \n24. Lim, J. K. H. et al. Retinal Functional and Structural Changes in the 5xFAD Mouse Model 586 \nof Alzheimer’s Disease. Front Neurosci 14, (2020). 587 \n25. Kim, T.-H., Son, T., Klatt, D. & Yao, X. Concurrent OCT and OCT angiography of retinal 588 \nneurovascular degeneration in the 5XFAD Alzheimer’s disease mice. Neurophotonics 8, 589 \n(2021). 590 \n26. Matei, N. et al. Retinal Vascular Physiology Biomarkers in a 5XFAD Mouse Model of 591 \nAlzheimer’s Disease. Cells 11, (2022). 592 \n27. Forner, S. et al. Systematic phenotyping and characterization of the 5xFAD mouse model 593 \nof Alzheimer’s disease. Sci Data 8, (2021). 594 \n28. Fialová, S. et al. Polarization properties of single layers in the posterior eyes of mice and 595 \nrats investigated using high resolution polarization sensitive optical coherence 596 \ntomography. Biomed Opt Express 7, 1479 (2016). 597 \n29. Augustin, M. et al. Multi-functional OCT enables longitudinal study of retinal changes in 598 \na VLDLR knockout mouse model. PLoS One 11, (2016). 599 \n30. Augustin, M., Harper, D. J., Merkle, C. W., Hitzenberger, C. K. & Baumann, B. 600 \nSegmentation of Retinal Layers in OCT Images of the Mouse Eye Utilizing Polarization 601 \nContrast. in Lecture Notes in Computer Science (including subseries Lecture Notes in 602 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint \n\n33 \nArtificial Intelligence and Lecture Notes in Bioinformatics) vol. 11039 LNCS 310–318 603 \n(Springer Verlag, 2018). 604 \n31. Morris, R. G. M. Spatial Localization Does Not Require the Presence of Local Cues. 605 \nLEARNING AND MOTIVATION vol. 12 (1981). 606 \n32. Löffler, T. et al. Impact of ApoB-100 expression on cognition and brain pathology in 607 \nwild-type and hAPPsl mice. Neurobiol Aging 34, 2379–2388 (2013). 608 \n33. Sil, A. et al. Sex Differences in Behavior and Molecular Pathology in the 5XFAD Model. 609 \nJournal of Alzheimer’s Disease 85, 751–774 (2022). 610 \n34. Batista, A. et al. Normative mice retinal thickness: 16-month longitudinal characterization 611 \nof wild-type mice and changes in a model of Alzheimer’s disease. Front Aging Neurosci 612 \n15, (2023). 613 \n  614 \n 615 \n 616 \nGeorg Ladurner has been a PhD student at the Medical University of Vienna since March 2023. 617 \nHe received his BS and MS degrees in physics from the LMU Munich  in 2020 and 2021, 618 \nrespectively. His current research interests include optical coherence tomography, Alzheimer’s 619 \ndisease, retinal diseases and retinal imaging techniques . He is a member of SPIE.  620 \n 621 \nBiographies and photographs for the other authors are not available. 622 \n 623 \n.CC-BY 4.0 International licenseavailable under a \nwas not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made \nThe copyright holder for this preprint (whichthis version posted May 28, 2025. ; https://doi.org/10.1101/2025.05.23.655771doi: bioRxiv preprint","source_license":"CC-BY-4.0","license_restricted":false}